Xitandi 40MG gcap 120S
Ended Awarded
- Contract number
- SPE2DX25FKVZR
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $4,839
Award facts
- Contract value 100% obligated
- $4,839.02 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $4,839.02 by the Defense Logistics Agency (DLA) Medical Supply Chain on September 2, 2025, with an ultimate completion date of September 3, 2025. The delivery order is for Xtandi 40mg capsules (120 count), a prescription oncology medication, under a firm fixed-price contract type with no set-aside designation. This award represents a single delivery order issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA valued at $499,999,999 through November 2026, which authorizes the agency to procure a comprehensive range of pharmaceutical products and medical supplies.
The delivery order supports the DLA's mission to supply pharmaceutical products to Department of Defense healthcare facilities nationwide. DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, leveraging its woman-owned small business status to compete effectively in federal procurement markets. The company's contract portfolio demonstrates extensive experience delivering specialized pharmaceutical products, including branded and generic prescription drugs, biologics, and medical consumables to military health facilities. This particular delivery order continues the company's track record of providing oncology treatments and other specialized medications to support DoD healthcare operations.
Quick answers
Who was awarded contract SPE2DX25FKVZR?
SPE2DX25FKVZR was awarded to DMS Pharmaceutical Group Inc. by Medical Supply Chain (Troop Support) on September 2, 2025.
How much is contract SPE2DX25FKVZR worth?
The government has obligated $4,839 on SPE2DX25FKVZR.
Is contract SPE2DX25FKVZR an order under another contract?
Yes. SPE2DX25FKVZR is a delivery order under SPE2DX15D9628, an indefinite delivery contract.
Was contract SPE2DX25FKVZR competed?
The extent of competition for SPE2DX25FKVZR was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award